# Effects of Statin for Elderly Patients With Atherosclerotic Cardiovascular Disease

Study · id `cardio:ct-nct04826354` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT04826354](<https://clinicaltrials.gov/study/NCT04826354>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT04826354

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 582 participants.

## Technical summary

Registry record NCT04826354. Randomized; no masking; primary purpose treatment. Start 2021-08-11 (actual); primary completion 2023-05-14 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 582 participants (enrolled count; ClinicalTrials.gov record NCT04826354, source copy `cardio:ctgov-nct04826354-2023-08-08`, retrieved 2026-10-26)
- Started: 2021-08-11 (actual) (ClinicalTrials.gov record NCT04826354, source copy `cardio:ctgov-nct04826354-2023-08-08`, retrieved 2026-10-26)
- Primary completion: 2023-05-14 (actual) (ClinicalTrials.gov record NCT04826354, source copy `cardio:ctgov-nct04826354-2023-08-08`, retrieved 2026-10-26)
- Completion: 2023-06-28 (actual) (ClinicalTrials.gov record NCT04826354, source copy `cardio:ctgov-nct04826354-2023-08-08`, retrieved 2026-10-26)
- Countries: South Korea (ClinicalTrials.gov record NCT04826354, source copy `cardio:ctgov-nct04826354-2023-08-08`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct04826354-2023-08-08`, retrieved 2026-10-26)

## The registry's words

- Brief title: Effects of Statin for Elderly Patients With Atherosclerotic Cardiovascular Disease
- Condition: Atheroscleroses, Coronary
- Intervention (Drug): Rosuvastatin and Ezetimibe
- Intervention (Drug): Rosuvastatin
- Lead sponsor: Korea University Anam Hospital
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Coronary artery disease (`cardio:coronary-artery-disease`)
- Registry intervention name matches this record: Rosuvastatin (`cardio:rosuvastatin`)
- Registry lists this organization as the lead sponsor: Korea University Anam Hospital (`cardio:org-korea-university-anam-hospital`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Metabolic and Safety Outcomes of Statin-Ezetimibe Versus High-Intensity Statin in Older Patients (`cardio:pubmed-42396798`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: 77fc4f50c6faca2b0ba36c0d9771ca07a6425696aea2ccfb4127f92858f7e92d
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
